Polycystic ovary syndrome (PCOS) is one of the most common reproductive endocrine
disorders in women and despite this, diagnostic challenges, delayed diagnosis, and less …

Glucagon like peptide-1 (GLP-1) is an incretin secretory molecule. GLP-1 receptor agonists
(GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their …

Study question What is the recommended assessment and management of those with
polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise …

In a healthy body, reactive oxygen species (ROS) and antioxidants remain balanced. When
the balance is broken toward an overabundance of ROS, oxidative stress appears and may …

As the gut microbiota exerts various effects on the intestinal milieu which influences distant
organs and pathways, it is considered to be a full-fledged endocrine organ. The microbiota …

Endocrine disrupting chemicals (EDCs) are ubiquitous in aquatic and terrestrial
environments. The main objective of this review was to summarize the current knowledge of …

Gestational diabetes mellitus (GDM) has become an epidemic and has caused a
tremendous healthy and economic burden in China, especially after the “two-child policy” …

Polycystic ovary syndrome (PCOS) is a heterogeneous disorder characterized by
hyperandrogenism and chronic anovulation. Depending on diagnostic criteria, 6% to 20% of …

Polycystic ovarian syndrome (PCOS) is a prevailing endocrine and metabolic disorder
occurring in about 6–20% of females in reproductive age. Most symptoms of PCOS arise …

Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic
disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a …